MY ACCOUNT | NEWSLETTER |

Hill’s Pet Nutrition unveils ONC Care, therapeutic food formulated for pets living with cancer

Prescription Diet ONC Care available in March in the U.S., rolling out globally through 2024


On Jan. 13, Hill’s Pet Nutrition unveiled Prescription Diet ONC Care, a new therapeutic food formulated to promote better food intake in pets living with cancer. In a news release, the company said this gives veterinarians an additional way to support their patients with each meal.

The new therapeutic product is designed to manage nutritional needs for dogs and cats and will be available in canned and dry forms or kibble, according to Dr. Karen Shenoy, U.S. chief veterinary officer of Hill’s Pet Nutrition. 

In an interview with Veterinary33 prior to the announcement, Shenoy said the company is committed to improving the lives of pets and the bond between pet parents and their companion animals. 

“It was an obvious place to go,” she said, citing that one in four dogs and one in five cats will develop cancer in their lifetime and the toll it takes on pet parents. “A large number of pets out there are unfortunately facing a diagnosis of cancer,” said Shenoy. “All pets need to eat, and we provide a high-quality product that supports them.” 

Shenoy said the new food contains highly digestible protein and high levels of essential amino acids. The formulation helps pets maintain lean muscle mass, which can be challenging. The new product also contains a blend of prebiotics made with Hill’s proprietary ActivBiome+ technology that help nourish the microbiome, ensuring that pets have a normal stool quality. 

It’s designed to help pets with all types of cancer have more energy, maintain their weight and increase their quality of life, she said in the interview. 

Available in the U.S. beginning in March 2023, the new Prescription Diet ONC Care is the result of five years of research and development to better meet the healthcare needs of pets diagnosed with cancer. Additional studies are underway to explore other clinical benefits of the new food. The innovation will continue to roll out globally throughout this year into 2024.

Currently, there is not a veterinary standard for managing the nutritional needs of oncology patients, nor is there a therapeutic food designed specifically to meet their needs, according to the company. 

According to a news release, general nutrition goals for pets with cancer include preserving lean muscle, minimizing metabolic disturbances and GI intolerance to food, and optimizing quality of life. These goals can be difficult to meet and pets with cancer often exhibit lethargy, inappetence and weight loss.

In the interview and news release, Shenoy also highlighted Hill’s 75th anniversary this year. As the company celebrates its anniversary, leaders and staff also look forward to bringing to the market this one-of-a-kind therapeutic product. 

Hill’s is a Platinum level sponsor of VMX and will have ONC Care on display at its booth #2004. For more information, visit HillsVet.com.

About Hill’s Pet Nutrition  

Founded 75 years ago with an unwavering commitment to science-led pet nutrition, Hill's Pet Nutrition is on a mission to help enrich and lengthen the special relationships between people and their pets. Hill's is dedicated to pioneering research for dogs and cats using a scientific understanding of their specific needs. As a leading veterinarian recommended pet food brand, knowledge is our first ingredient with 220+ veterinarians, PhD nutritionists and food scientists working to develop breakthrough innovations in pet health. Hill's Prescription Diet therapeutic nutrition plus our everyday foods, Hill's Science Diet, Hill's Healthy Advantage and Hill's Bioactive Recipe, are sold at vet clinics and pet specialty retailers worldwide. For more information about our products and nutritional philosophy, visit HillsPet.com or HillsVet.com. To learn more about Hill's Food, Shelter & Love program, visit hillspet.com/shelter

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

World Veterinary Dermatology Day

Like0
Dislike0

Artificial insemination market to grow to $3B by 2028

Like0
Dislike0

February is National Pet Dental Health Month

Like0
Dislike0

Falling markets? Don't panic, it's not the first time

Like0
Dislike0

Treatment of canine chronic cutaneous lupus erythematosus with oclacitinib

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2023 - All Rights Reserved
ISSN 2768-198X

Top